CAJ | 학술논문

目的探讨手术切除联合辅助治疗对局部复发性直肠癌的治疗效果.方法对1993年8月至2002年2月间收治的107例局部复发再治疗者采用不同治疗方法的临床疗效进行回顾性分析.结果手术联合辅助治疗组(A组)32例,单纯手术组(B组)37例,单独辅助治疗组(C组)38例,三组中位年龄分别为:49.3±20.7、44.4±25.4、52.9±29.1岁.A、B、C组中位生存期分别为27.8、14.6、13.7个月.A组5年生存率显著优于B组(X2=6.862,P＜0.05)和C组(X2=4.286,P＜0.05).结论对于复发性直肠癌行包括手术在内的综合治疗可延长患者的生存期.
목적 탐토수술절제연합보조치료대국부복발성직장암적치료효과.방법 대1993년8월지2002년2월간수치적107례국부복발재치료자채용불동치료방법적림상료효진행회고성분석.결과 수술연합보조치료조(A조)32례,단순수술조(B조)37례,단독보조치료조(C조)38례,삼조중위년령분별위:49.3±20.7、44.4±25.4、52.9±29.1세.A、B、C조중위생존기분별위27.8、14.6、13.7개월.A조5년생존솔현저우우B조(X2=6.862,P＜0.05)화C조(X2=4.286,P＜0.05).결론 대우복발성직장암행포괄수술재내적종합치료가연장환자적생존기.
Objective To explore the efficacy of treatment for locally recurrent rectal cancer after radical surgery. Methods In this study,the management of 107 patients with postoperative locally recurrence of rectal carcinoma admitted from August 1993 to February 2002 was retrospectively analyzed.Results Thirty-two cases were treated by reoperation combined with adjuvant therapy(group A),37 cases underwent ressction alone(group B),38 patients received adjuvant therapy alone(group C).The age of these patients was 49.3±20.7,44.4±25.4,and 52.9±29.1 respectively.The median survival time after treatment was 27.8,14.6,and 13.7 months,respectively.The five year's survival of patients in group A was better than that in group B and group C significantly(P＜0.05).Conclusions The aggressive surgery combined with adjuvant therapy improves the survival of the patients with locally recurrent rectal cancer after radical surgery.